Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

被引:1453
|
作者
Hara, K [1 ]
Maruki, Y
Long, XM
Yoshino, K
Oshiro, N
Hidayat, S
Tokunaga, C
Avruch, J
Yonezawa, K
机构
[1] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan
[2] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Dept Mol Biol, Boston, MA 02114 USA
关键词
D O I
10.1016/S0092-8674(02)00833-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
mTOR controls cell growth, in part by regulating p70 S6 kinase alpha (p70alpha) and eukaryotic initiation factor 4E binding protein 1 (4EBP1). Raptor is a 150 kDa mTOR binding protein that also binds 4EBP1 and p70alpha. The binding of raptor to mTOR is necessary for the mTOR-catalyzed phosphorylation of 4EBP1 in vitro, and it strongly enhances the mTOR kinase activity toward p70alpha. Rapamycin or amino acid withdrawal increases, whereas insulin strongly inhibits, the recovery of 4EBP1 and raptor on 7-methyl-GTP Sepharose. Partial inhibition of raptor expression by RNA interference (RNAi) reduces mTOR-catalyzed 4EBP1 phosphorylation in vitro. RNAi of C. elegans raptor yields an array of phenotypes that closely resemble those produced by inactivation of Ce-TOR. Thus, raptor is an essential scaffold for the mTOR-catalyzed phosphorylation of 4EBP1 and mediates TOR action in vivo.
引用
收藏
页码:177 / 189
页数:13
相关论文
共 50 条
  • [42] Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1
    Beugnet, A
    Wang, XM
    Proud, CG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 40717 - 40722
  • [43] Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity
    da Silva, Luciana Madeira
    Beverley, Stephen M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (26) : 11965 - 11970
  • [44] Trypanosomal target of rapamycin: Repurposing of mammalian TOR inhibitors for neglected disease drug discovery
    Hubbard, Caitlin E.
    Beverley, Stephen M.
    Diaz, Rosario
    Madeira da Silva, Luciana
    Navarro, Miguel
    Ondrechen, Mary J.
    Wang, Zhouxi
    Pollastri, Michael P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [45] Phylogenetic analysis of target of rapamycin (TOR) kinase gene of some selected plants species
    Sapre, Swapnil
    Tiwari, Sharad
    Thakur, Vishwa Vijay
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2018, 11 (03): : 476 - 480
  • [46] Hydrogen peroxide modulates the expression of the target of rapamycin (TOR) and cell division in Arabidopsis thaliana
    Hernandez-Esquivel, Alma Alejandra
    Torres-Olmos, Jorge Alejandro
    Mendez-Gomez, Manuel
    Castro-Mercado, Elda
    Flores-Cortez, Idolina
    Pena-Uribe, Cesar Arturo
    Campos-Garcia, Jesus
    Lopez-Bucio, Jose
    Reyes-de la Cruz, Homero
    Valencia-Cantero, Eduardo
    Garcia-Pineda, Ernesto
    PROTOPLASMA, 2024, 261 (06) : 1147 - 1158
  • [47] A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR)
    Chan, TF
    Carvalho, J
    Riles, L
    Zheng, XFS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) : 13227 - 13232
  • [48] Target of Rapamycin (TOR)-Based Therapy for Cardiomyopathy: Evidence From Zebrafish and Human Studies
    Kushwaha, Sudhir
    Xu, Xiaolei
    TRENDS IN CARDIOVASCULAR MEDICINE, 2012, 22 (02) : 39 - 43
  • [49] Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations - Introduction
    Hricik, DE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S1 - S2
  • [50] The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif
    Nojima, H
    Tokunaga, C
    Eguchi, S
    Oshiro, N
    Hidayat, S
    Yoshino, K
    Hara, K
    Tanaka, N
    Avruch, J
    Yonezawa, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 15461 - 15464